Attached files
| file | filename |
|---|---|
| 10-Q/A - AMENDMENT NO. 1 TO FORM 10-Q - H-CYTE, INC. | mdvx10qa_mar312015.htm |
| EX-31.1 - SECTION 302 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER - H-CYTE, INC. | ex31-1.htm |
| EX-31.2 - SECTION 302 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER - H-CYTE, INC. | ex31-2.htm |
EXHIBIT 32.1
|
|
CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND
|
|
|
CHIEF FINANCIAL OFFICER PURSUANT TO RULE 13a-14(b) UNDER
|
|
|
THE SECURITIES EXCHANGE ACT OF 1934 AND SECTION 1350 OF
|
|
|
CHAPTER 63 OF TITLE 18 OF THE UNITED STATES CODE
|
|
|
|
Each of the undersigned, Jarrett Gorlin and Jeffery Wright, certifies pursuant to Rule 13a-14(b) under the Securities Exchange Act of 1934 and Section 1350 of Chapter 63 of Title 18 of the United States Code, that (1) this quarterly report on Form 10-Q/A for the quarter ended March 31, 2015, of MedoveX Corp. (the “Company”) fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934, and (2) the information contained in this report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date: January 8, 2016
|
/s/ Jarrett Gorlin
|
|
|
Jarrett Gorlin,
|
|
|
Chief Executive Officer
|
|
|
/s/ Jeffery Wright
|
|
|
Jeffery Wright,
|
|
|
Chief Financial Officer
|